Inhibrx Biosciences (INBX) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $5.7 million.
- Inhibrx Biosciences' Other Non-Current Assets fell 1451.13% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 1451.13%. This contributed to the annual value of $6.8 million for FY2024, which is 11589.76% up from last year.
- As of Q3 2025, Inhibrx Biosciences' Other Non-Current Assets stood at $5.7 million, which was down 1451.13% from $6.8 million recorded in Q2 2025.
- Over the past 5 years, Inhibrx Biosciences' Other Non-Current Assets peaked at $6.8 million during Q4 2024, and registered a low of $3.2 million during Q4 2023.
- Over the past 3 years, Inhibrx Biosciences' median Other Non-Current Assets value was $6.7 million (recorded in 2024), while the average stood at $6.1 million.
- Per our database at Business Quant, Inhibrx Biosciences' Other Non-Current Assets surged by 11589.76% in 2024 and then plummeted by 1451.13% in 2025.
- Quarter analysis of 3 years shows Inhibrx Biosciences' Other Non-Current Assets stood at $3.2 million in 2023, then soared by 115.9% to $6.8 million in 2024, then decreased by 16.0% to $5.7 million in 2025.
- Its Other Non-Current Assets was $5.7 million in Q3 2025, compared to $6.8 million in Q2 2025 and $6.8 million in Q1 2025.